摘要
Context: Previous data support an association between polymorphisms of the β1-and β2-adrenergic receptors(ADRB1 and ADRB2) and surrogate end points of response to β-adrenergic blocker therapy. However, no associations between these polymorphisms and mortality have been demonstrated. Objective: To ev...
-
单位Washington University ,School of Medicine; Washington University School of Medicine